Absolutely, and particularly for expensive drugs for less common diseases. I think there's tremendous merit in examining our model for that.
On May 2nd, 2016. See this statement in context.
On May 2nd, 2016. See this statement in context.
Chief Executive Officer, Canadian Blood Services
Absolutely, and particularly for expensive drugs for less common diseases. I think there's tremendous merit in examining our model for that.
See context to find out what was said next.